Six RCM Tips from the ADLM 2026 Meeting
Watch for panel unbundling, Medicare spending shifts, and frequency-based denials
Watch for panel unbundling, Medicare spending shifts, and frequency-based denials
Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate
These core steps are fundamental for protecting laboratory workers from airborne contamination
The proposal seeks to move any future LDT authority away from the FDA
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Deal could prove a boost to the company, which has struggled since 2023
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Hologic has been on the vanguard of developing and distributing tests focusing on women’s health
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams